Free Trial

Genpact Limited (NYSE:G) Shares Bought by Vest Financial LLC

Genpact logo with Business Services background

Vest Financial LLC lifted its stake in Genpact Limited (NYSE:G - Free Report) by 36.0% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 78,543 shares of the business services provider's stock after purchasing an additional 20,792 shares during the period. Vest Financial LLC's holdings in Genpact were worth $3,957,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. State of New Jersey Common Pension Fund D acquired a new stake in shares of Genpact during the fourth quarter worth about $2,030,000. Pictet Asset Management Holding SA purchased a new position in Genpact during the fourth quarter worth about $921,000. Proficio Capital Partners LLC acquired a new stake in shares of Genpact in the 4th quarter valued at approximately $983,000. Cetera Investment Advisers boosted its position in shares of Genpact by 4.7% during the 4th quarter. Cetera Investment Advisers now owns 13,269 shares of the business services provider's stock worth $570,000 after purchasing an additional 595 shares in the last quarter. Finally, 111 Capital acquired a new position in shares of Genpact during the 4th quarter worth $301,000. 96.03% of the stock is owned by institutional investors and hedge funds.

Genpact Stock Up 1.1%

Genpact stock traded up $0.46 during trading on Tuesday, reaching $43.66. 1,381,795 shares of the company's stock were exchanged, compared to its average volume of 1,381,959. The company's 50-day moving average is $45.73 and its two-hundred day moving average is $47.19. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 2.16. Genpact Limited has a 52-week low of $30.38 and a 52-week high of $56.76. The firm has a market cap of $7.63 billion, a price-to-earnings ratio of 15.37, a PEG ratio of 1.84 and a beta of 0.94.

Genpact (NYSE:G - Get Free Report) last announced its earnings results on Wednesday, May 7th. The business services provider reported $0.84 EPS for the quarter, beating the consensus estimate of $0.80 by $0.04. The business had revenue of $1.21 billion for the quarter, compared to the consensus estimate of $1.21 billion. Genpact had a return on equity of 22.50% and a net margin of 10.77%. The company's revenue was up 7.4% on a year-over-year basis. During the same period last year, the business posted $0.73 EPS. On average, analysts predict that Genpact Limited will post 3.21 earnings per share for the current year.

Genpact Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Wednesday, June 18th will be paid a dividend of $0.17 per share. The ex-dividend date of this dividend is Wednesday, June 18th. This represents a $0.68 annualized dividend and a dividend yield of 1.56%. Genpact's dividend payout ratio is presently 23.21%.

Analysts Set New Price Targets

A number of analysts recently commented on the stock. Wall Street Zen raised shares of Genpact from a "buy" rating to a "strong-buy" rating in a report on Friday. Mizuho increased their target price on Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a report on Monday, February 10th. Needham & Company LLC dropped their price target on Genpact from $55.00 to $50.00 and set a "buy" rating for the company in a research report on Thursday, May 8th. Finally, Robert W. Baird reduced their target price on shares of Genpact from $56.00 to $50.00 and set a "neutral" rating on the stock in a report on Thursday, May 8th. Four research analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $50.71.

Read Our Latest Stock Report on Genpact

Insider Transactions at Genpact

In other news, CEO Balkrishan Kalra sold 13,600 shares of Genpact stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $48.89, for a total value of $664,904.00. Following the completion of the transaction, the chief executive officer now directly owns 310,246 shares of the company's stock, valued at approximately $15,167,926.94. The trade was a 4.20% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Nicholas C. Gangestad acquired 2,000 shares of the company's stock in a transaction that occurred on Tuesday, May 13th. The shares were acquired at an average price of $43.97 per share, for a total transaction of $87,940.00. Following the purchase, the director now owns 2,000 shares of the company's stock, valued at $87,940. This trade represents a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 3.07% of the company's stock.

Genpact Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Read More

Institutional Ownership by Quarter for Genpact (NYSE:G)

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Goldman Sachs Warns of 20% Market Drop—Are They Right?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines